title: [Administration of prostacyclin in sudden deafness. Evaluation with the double blind method].
abstract: Prostacyclin (PGI2) connects all the pharmacologic properties of drugs being used till now in sudden deafness. 30 patients with sensori-neural sudden deafness were treated by prostacyclin and placebo in the double-blind test situation. In therapeutic group of 15 patients were 87% of complete recovery, but in placebo only 6%.
authors.affiliation: Kliniki Otolaryngologii AM w Krakowie.
authors.forename: E
authors.initials: E
authors.lastname: Olszewski
authors.forename: E
authors.initials: E
authors.lastname: Kostka-Trabka
authors.forename: E
authors.initials: E
authors.lastname: Reroń
authors.forename: L
authors.initials: L
authors.lastname: Grodzińska
authors.forename: J
authors.initials: J
authors.lastname: Turek
authors.forename: A
authors.initials: A
authors.lastname: Dembińska-Kieć
authors.forename: K
authors.initials: K
authors.lastname: Bieroń
authors.forename: M
authors.initials: M
authors.lastname: Basista
authors.forename: A
authors.initials: A
authors.lastname: Kedzior
authors.forename: M
authors.initials: M
authors.lastname: Sławiński
mesh_terms: D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D003639:Hearing Loss, Sudden / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D011464:Epoprostenol
vernacular_title: Zastosowanie prostacykliny w nagłej głuchocie. Ocena metoda "podwójnie ślepej próby".